Tocilizumab-Induced Unexpected Increase of Several Inflammatory Cytokines in Critically Ill COVID-19 Patients: The Anti-Inflammatory Side of IL-6.
|
Jan/27/2022 |
The JAK inhibitor ruxolitinib abrogates immune hepatitis instigated by concanavalin A in mice.
|
Dec/21/2021 |
Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine.
|
May/24/2022 |
Epitope based peptide vaccine against SARS-COV2: an immune-informatics approach.
|
Feb/01/2022 |
Biotin Functionalized Self-Assembled Peptide Nanofiber as an Adjuvant for Immunomodulatory Response.
|
Sep/14/2021 |
Nursing of Patients Critically Ill With Coronavirus Disease Treated With Extracorporeal Membrane Oxygenation.
|
Feb/24/2022 |
Future perspective: biologic agents in patients with severe COVID-19.
|
May/03/2020 |
Antiviral effect of fufang yinhua jiedu (FFYH) granules against influenza A virus through regulating the inflammatory responses by TLR7/MyD88 signaling pathway.
|
May/23/2020 |
Resveratrol-mediated attenuation of superantigen-driven acute respiratory distress syndrome is mediated by microbiota in the lungs and gut.
|
Mar/15/2021 |
Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri Lanka.
|
Nov/08/2021 |
A rational design of a multi-epitope vaccine against SARS-CoV-2 which accounts for the glycan shield of the spike glycoprotein.
|
Feb/16/2022 |
Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved.
|
May/13/2022 |
COVID-19 Updates: Pfizer-BioNTech COVID-19 vaccine.
|
Jun/15/2021 |
Anti-Inflammatory Effects of Immunostimulation in Patients with COVID-19 Pneumonia.
|
Oct/07/2021 |
Predictive factors of a viral neutralizing humoral response after a third dose of COVID-19 mRNA vaccine in kidney transplant recipients.
|
Jul/22/2021 |
Identification of HLA-A2 restricted CD8+ T cell epitopes in SARS-CoV-2 structural proteins.
|
Jul/07/2021 |
Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein.
|
Dec/17/2021 |
mRNA Vaccine Protects against Zika Virus.
|
Dec/10/2021 |
[Interferon gamma in the treatment of patients with moderate COVID-19].
|
Jan/06/2022 |
Status of Humoral and Cellular Immune Responses within 12 Months following CoronaVac Vaccination against COVID-19.
|
May/19/2022 |
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up.
|
Dec/03/2020 |
[Study on therapeutic effect of Chaiyin Particles on combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome based on regulation of immune function].
|
Feb/13/2022 |
Computational profiling of natural compounds as promising inhibitors against the spike proteins of SARS-CoV-2 wild-type and the variants of concern, viral cell-entry process, and cytokine storm in COVID-19.
|
Dec/11/2020 |
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study.
|
Mar/11/2022 |
Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial.
|
Jan/17/2022 |
[Therapeutic effect of Compound Qinlan Oral Liquid on treating combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome].
|
Feb/07/2022 |
Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab.
|
May/02/2022 |
Nucleocapsid protein of SARS-CoV-2 is a potential target for developing new generation of vaccine.
|
May/09/2022 |
Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines.
|
Nov/20/2020 |
Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir
|
Jun/28/2021 |
Aluminum Nanoparticles Acting as a Pulmonary Vaccine Adjuvant-Delivery System (VADS) Able to Safely Elicit Robust Systemic and Mucosal Immunity
|
Feb/24/2021 |
Identification of Novel T-Cell Epitopes on Infectious Bronchitis Virus N Protein and Development of a Multi-epitope Vaccine.
|
Aug/10/2021 |
Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection
|
Jun/25/2020 |
An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases
|
Jan/05/2021 |
Young infants exhibit robust functional antibody responses and restrained IFN-gamma production to SARS-CoV-2.
|
Jun/09/2021 |
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study
|
Mar/23/2022 |
Induction of humoral and cellular immune responses to COVID-19 mRNA and vector vaccines: A prospective cohort study in Bulgarian healthcare workers
|
Jan/18/2022 |
Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine
|
Jan/19/2022 |
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications
|
Jan/17/2022 |
Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools
|
May/30/2020 |
Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response
|
Apr/11/2022 |
Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients
|
Aug/30/2020 |
mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients
|
Feb/15/2022 |
Cytotoxic T lymphocytes targeting a conserved SARS-CoV-2 spike epitope are efficient serial killers
|
Jun/30/2020 |
Development of an mRNA-LNP Vaccine against SARS-CoV-2: Evaluation of Immune Response in Mouse and Rhesus Macaque.
|
Sep/10/2021 |
Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation.
|
Jun/17/2021 |
The temporal course of T- and B-cell-responses to vaccination with BNT162b2 and mRNA-1273
|
Sep/20/2021 |
B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic Patients
|
Mar/01/2022 |
Peptides Derived From S and N Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Induce T Cell Responses: A Proof of Concept for T Cell Vaccines
|
Sep/24/2021 |
Evaluation of Cell-Penetrating Peptides as Mucosal Immune Enhancers for Nasal Vaccination
|
Apr/20/2020 |
Cell therapy in patients with COVID-19 using Wharton's jelly mesenchymal stem cells: a phase 1 clinical trial
|
Jul/16/2021 |
Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination
|
May/23/2020 |
Acute exercise increases immune responses to SARS CoV-2 in a previously infected man.
|
Sep/22/2021 |
CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination
|
Nov/30/2021 |
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting
|
Jul/11/2020 |
The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-gamma production in vitro.
|
May/19/2021 |
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
|
Jul/20/2021 |
Nafamostat reduces systemic inflammation in TLR7-mediated virus-like illness
|
Jan/06/2022 |
Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study
|
Sep/15/2021 |
A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis
|
Nov/29/2021 |
Ultraviolet-A light reduces cellular cytokine release from human endotracheal cells infected with Coronavirus.
|
Jul/24/2021 |
SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy.
|
Nov/07/2021 |
Synthetic SARS-CoV-2 Spike-Based DNA Vaccine Elicits Robust and Long-Lasting Th1 Humoral and Cellular Immunity in Mice
|
May/22/2020 |
A Single Dose of Self-Transcribing and Replicating RNA Based SARS-CoV-2 Vaccine Produces Protective Adaptive Immunity In Mice.
|
Apr/05/2021 |
A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial
|
Jan/12/2022 |
B and T cell immune responses elicited by the Comirnaty COVID-19 vaccine in nursing home residents
|
Jun/24/2021 |
The ROMANOV study found impaired humoral and cellular immune responses to SARSCov-2 mRNA vaccine in virus unexposed patients receiving maintenance hemodialysis.
|
May/31/2021 |
Integrated hepatic single-cell RNA sequencing and untargeted metabolomics reveals the immune and metabolic modulation of Qing-Fei-Pai-Du decoction in mice with coronavirus-induced pneumonia.
|
Jan/02/2022 |
SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
|
Jul/27/2021 |
Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein
|
Mar/25/2022 |
"Small" Intestinal Immunopathology Plays a "Big" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-gamma, IL-17A, and a Janus Kinase Inhibitor
|
Jun/26/2020 |
Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model.
|
May/24/2021 |
MSC-NTF (NurOwn ) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model
|
Jan/19/2021 |
Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2
|
Jan/29/2021 |
Neutralizing Antibodies and Cellular Immune Responses Against SARS-CoV-2 Sustained One and a Half Years After Natural Infection
|
Mar/12/2021 |
Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS via Inhibiting TLR4/NF-kB Pathway and NLRP3 Inflammasome Activation
|
Dec/31/2021 |
Prompt Reduction in CRP, IL-6, IFN-gamma, IP-10, and MCP-1 and a Relatively Low Basal Ratio of Ferritin/CRP Is Possibly Associated With the Efficacy of Tocilizumab Monotherapy in Severely to Critically Ill Patients With COVID-19
|
Sep/23/2021 |
Evaluation of the Immune Response Induced by CoronaVac 28-Day Schedule Vaccination in a Healthy Population Group
|
Jan/31/2022 |
Rapid and sustained decline in CXCL-10 (IP-10) annotates clinical outcomes following TNFalpha-antagonist therapy in hospitalized patients with severe and critical COVID-19 respiratory failure.
|
Jun/25/2021 |
Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization
|
Feb/06/2021 |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC-COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study.
|
Jun/26/2021 |
Possible therapeutic effects of Nigella sativa and its thymoquinone on COVID-19
|
Feb/07/2022 |
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial
|
Jan/07/2022 |
Kinetics of Severity Biomarkers and Immunological Features of Methylprednisolone Therapy for Severe COVID-19 Patients
|
Mar/08/2022 |
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
|
Aug/10/2021 |
Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations.
|
Jul/05/2021 |
Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation.
|
Mar/10/2021 |
COVID-19 convalescent plasma composition and immunological effects in severe patients.
|
Jan/22/2021 |
Improvement of clinical outcome, laboratory findings and inflammatory cytokines levels using plasmapheresis therapy in severe COVID-19 cases.
|
Oct/26/2021 |
Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria
|
May/11/2021 |
Humoral and cellular immune responses to SARS CoV-2 vaccination in Persons with Multiple Sclerosis and NMOSD patients receiving immunomodulatory treatments
|
Oct/30/2020 |
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study.
|
Aug/13/2021 |
Efficacy and Safety of Ergoferon in Children from 6 Months to 6 Years Old with Acute Respiratory Viral Infections in Contemporary Outpatient Practice: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial.
|
Nov/15/2021 |
Beneficial effect of Indigo Naturalis on acute lung injury induced by influenza A virus.
|
Dec/21/2020 |
Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19
|
Nov/27/2020 |
Three Specific Potential Epitopes That Could Be Recognized by T Cells of Convalescent COVID-19 Patients Were Identified From Spike Protein
|
Jul/30/2021 |
Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine.
|
Apr/22/2022 |
Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates
|
May/18/2021 |
Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation.
|
Jun/19/2020 |
The Effects of Insulin-Like Growth Factor I and BTP-2 on Acute Lung Injury.
|
May/15/2021 |
Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy
|
May/12/2021 |
T cell-mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19
|
Oct/30/2020 |
Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis
|
Feb/01/2022 |
A Self-Biomineralized Novel Adenovirus Vectored COVID-19 Vaccine for Boosting Immunization of Mice
|
Sep/28/2021 |
Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity.
|
Jun/01/2021 |
Low Doses of Radiation Increase the Immunosuppressive Profile of Lung Macrophages During Viral Infection and Pneumonia.
|
Mar/13/2021 |
Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients
|
Nov/17/2021 |
Bee Venom:A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections
|
Oct/30/2020 |
SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study
|
Apr/14/2022 |
Humoral and Cellular Responses to COVID-19 Vaccines in SARS-CoV-2 Infection-Naive and -Recovered Korean Individuals
|
Feb/18/2022 |
Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection
|
Aug/28/2021 |
Persistence of Antibody and Cellular Immune Responses in COVID-19 patients over Nine Months after Infection
|
Jul/14/2021 |
SARS-CoV2 wild type and mutant specific humoral and T cell immunity is superior after vaccination than after natural infection
|
Jan/29/2022 |
Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors
|
Jun/26/2021 |
Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab.
|
Aug/19/2021 |
Circulating CD4 T cells elicited by endemic coronaviruses display vast disparities in abundance and functional potential linked to both antigen specificity and age
|
Aug/10/2021 |
Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine
|
Jun/12/2021 |
Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients
|
Mar/05/2022 |
The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner.
|
Jun/03/2021 |
Identification of HLA-A*02:01-Restricted Candidate Epitopes Derived from the Nonstructural Polyprotein 1a of SARS-CoV-2 That May Be Natural Targets of CD8+ T Cell Recognition In Vivo
|
Dec/02/2020 |
Exploration of surface glycoprotein to design multi-epitope vaccine for the prevention of Covid-19.
|
Oct/04/2020 |
SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses
|
Sep/25/2021 |
Humoral and cellular immune response elicited by mRNA vaccination against SARS-CoV-2 in people living with HIV (PLWH) receiving antiretroviral therapy (ART) according with current CD4 T-lymphocyte count
|
Mar/04/2022 |
TNF-alpha+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies.
|
May/03/2022 |
SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine
|
Mar/14/2022 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
|
Nov/15/2021 |
Effects of Short-Term Corticosteroid Use on Reactogenicity and Immunogenicity of the First Dose of ChAdOx1 nCoV-19 Vaccine
|
Sep/22/2021 |
Innate Immune Responses of Vaccinees Determine Early Neutralizing Antibody Production After ChAdOx1nCoV-19 Vaccination
|
Jan/25/2022 |
E4orf1 Suppresses E1B-Deleted Adenovirus Vaccine-Induced Immune Responses
|
Feb/15/2022 |
Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study.
|
Dec/30/2021 |
Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates.
|
May/13/2021 |
Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod
|
Sep/08/2020 |
SARS-COV-2 Memory B and T Cells Profile in Mild COVID-19 Convalescents subjects
|
Apr/23/2021 |
Systemic IL-15, IFN-gamma, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients.
|
Jul/23/2021 |
The Cholinergic Drug Pyridostigmine Alleviates Inflammation During LPS-Induced Acute Respiratory Distress Syndrome
|
May/04/2021 |
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
|
Dec/15/2020 |
Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis.
|
Sep/02/2021 |
Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques.
|
Dec/29/2020 |
Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo
|
Jun/17/2020 |
A Murine CD8+ T Cell Epitope Identified in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein.
|
Jun/11/2021 |
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis
|
Sep/01/2021 |
Comparison of Wild Type DNA Sequence of Spike Protein from SARS-CoV-2 with Optimized Sequence on The Induction of Protective Responses Against SARS-Cov-2 Challenge in Mouse Model
|
Jan/21/2022 |
Nrf2 Activator PB125 as a Potential Therapeutic Agent against COVID-19
|
Nov/01/2021 |
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
|
Nov/12/2021 |
Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein
|
Jun/24/2021 |
Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination
|
Feb/01/2022 |
Kabasura Kudineer (KSK), a poly-herbal Siddha medicine, reduced SARS-CoV-2 viral load in asymptomatic COVID-19 individuals as compared to vitamin C and zinc supplementation: findings from a prospective, exploratory, open-labeled, comparative, randomized c
|
Sep/15/2021 |
Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine
|
May/28/2021 |
Ruxolitinib, a JAK1/2 Inhibitor, Ameliorates Cytokine Storm in Experimental Models of Hyperinflammation Syndrome.
|
Apr/22/2021 |
COVID-19 Subunit Vaccine with a Combination of TLR1/2 and TLR3 Agonists Induces Robust and Protective Immunity
|
Feb/04/2022 |
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
|
May/12/2020 |
Antiviral effects of human placenta hydrolysate (Laennec ) against SARS-CoV-2 in vitro and in the ferret model
|
Oct/06/2021 |
Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens.
|
Aug/14/2021 |
The oral vaccine based on self-replicating RNA lipid nanoparticles can simultaneously neutralize both SARS-CoV-2 variants alpha and delta
|
Nov/24/2021 |
Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID-19 patients Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID-19 patients
|
Jul/28/2020 |
Dominant CD8+ T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination
|
Nov/14/2021 |
Fecal microbiota transplantation for COVID-19; a potential emerging treatment strategy.
|
Dec/31/2020 |
Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine.
|
Jun/16/2021 |
Elevated CD21low B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency
|
Mar/15/2022 |
SARS-CoV-2-reactive interferon-gamma-producing CD8+ T cells in patients hospitalized with coronavirus disease 2019
|
Jun/15/2020 |
Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection
|
May/08/2021 |
Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency
|
Nov/17/2021 |
17alpha-Hydroxyprogesterone Caproate Inhibits Cytokine Production via Suppression of NF-kappaB Activation
|
Feb/07/2022 |
Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice
|
Nov/05/2021 |
Design of a Novel Multi Epitope-Based Vaccine for Pandemic Coronavirus Disease (COVID-19) by Vaccinomics and Probable Prevention Strategy against Avenging Zoonotics
|
Jul/02/2020 |
SARS-CoV-2-specific serological and functional T cell immune responses during acute and early COVID-19 convalescence in solid organ transplant patients
|
Apr/12/2021 |
Multi-Epitope Vaccine Design Using an Immunoinformatic Approach for SARS-CoV-2.
|
Jun/11/2021 |
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy
|
Jul/01/2021 |
Effect of BTN162b2 and CoronaVac boosters on humoral and cellular immunity of individuals previously fully vaccinated with CoronaVac against SARS-CoV-2: A longitudinal study
|
Feb/15/2021 |
Immunological analysis of the murine anti-CD3-induced cytokine release syndrome model and therapeutic efficacy of anti-cytokine antibodies
|
May/19/2021 |
Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response
|
Apr/21/2020 |
Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2
|
Feb/16/2021 |
Detection of Antibodies Against the SARS-CoV-2 Spike Protein and Analysis of the Peripheral Blood Mononuclear Cell Transcriptomic Profile, 15 Years After Recovery From SARS
|
Nov/18/2021 |
T cell response after SARS-CoV-2 vaccination in immunocompromised patients with inflammatory bowel disease
|
Dec/08/2021 |
Evaluation of Immune Response and Disease Status in SLE Patients Following SARS-CoV-2 Vaccination
|
Dec/28/2021 |
Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction
|
Oct/19/2021 |
The Effect of Anti-Chemokine Oral Drug XC8 on Cough Triggered by The Agonists of TRPA1 But Not TRPV1 Channels in Guinea Pigs
|
Apr/18/2020 |
Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients
|
Oct/30/2021 |
Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
|
Jan/06/2022 |
Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach.
|
Jul/27/2020 |
Safety and Cross-Variant Immunogenicity of a Three-dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients
|
Jan/20/2022 |
PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19
|
Nov/30/2020 |
Determinants of Immune Response to Anti-SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients: A Prospective Cohort Study
|
Feb/25/2020 |
SARS-CoV-2-specific CD8+ T-cell responses and TCR signatures in the context of a prominent HLA-A*24:02 allomorph
|
Sep/30/2021 |
Kinetics and persistence of cellular and humoral immune responses to SARS-CoV-2 vaccine in healthcare workers with or without prior COVID-19
|
Jan/18/2022 |
Successive Site Translocating Inoculation Improved T Cell Responses Elicited by a DNA Vaccine Encoding SARS-CoV-2 S Protein
|
Nov/01/2020 |
TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2
|
Jun/17/2021 |
Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination.
|
Jun/08/2021 |
Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people.
|
Aug/20/2021 |
mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects
|
Aug/27/2020 |
Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies
|
Feb/14/2022 |
Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients.
|
Aug/08/2021 |
ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients
|
Sep/14/2021 |
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
|
Apr/28/2020 |
Effect of a single high dose of Vitamin D3 on cytokines, chemokines and growth factor in patients with moderate to severe COVID-19
|
Aug/30/2021 |
Phase 1/2 clinical trial of COVID-19 vaccine in Japanese participants: A report of interim findings
|
Sep/10/2020 |
Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine Dose
|
Apr/17/2020 |
Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen In vivo
|
Dec/16/2020 |
Safety and Immunogenicity of a Booster Vaccination by CoronaVac or BNT162b2 in Previously Two-Dose Inactivated Virus Vaccinated Individuals with Negative Neutralizing Antibody
|
Jan/19/2022 |
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women.
|
May/13/2021 |
The impact of viral mutations on recognition by SARS-CoV-2 specific T-cells
|
Oct/28/2021 |
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.
|
Jun/23/2021 |
SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.
|
Jul/07/2021 |
Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2
|
Jun/24/2021 |
The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-gamma release by natural killer cells
|
Mar/18/2022 |
Designing and characterization of a SARS-CoV-2 immunogen with receptor binding motif grafted on a protein scaffold: An epitope-focused vaccine approach
|
Apr/22/2022 |
SARS-CoV-2-reactive T-cell receptors isolated from convalescent COVID-19 patients confer potent T-cell effector function
|
Sep/29/2021 |
Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV.
|
Nov/18/2021 |
Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: a case series
|
Sep/21/2021 |
The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors
|
Mar/16/2022 |
Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro
|
Apr/01/2022 |
Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19
|
Sep/16/2021 |
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study.
|
Sep/01/2021 |
SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans.
|
Oct/16/2020 |
Identifying SARS-CoV-2 'memory' NK cells from COVID-19 convalescent donors for adoptive cell therapy
|
Dec/02/2021 |
Immunoinformatics prediction of overlapping CD8+ T-cell, IFN-gamma and IL-4 inducer CD4+ T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2)
|
Jan/05/2022 |
Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs
|
Sep/15/2021 |
T Cell Immunity Evaluation and Immunodominant Epitope T Cell Receptor Identification of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein in COVID-19 Convalescent Patients
|
May/25/2021 |
SARS-CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice
|
Apr/13/2021 |
Detection of SARS-CoV-2-independent immunoregulatory activity of COVID-19 convalescent plasma
|
Oct/08/2021 |
A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients
|
Sep/19/2021 |
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab
|
Feb/22/2022 |
Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial.
|
May/16/2022 |
Impact of an Immune Modulator Mycobacterium-w on Adaptive Natural Killer Cells and Protection Against COVID-19.
|
May/04/2022 |
Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection.
|
Oct/05/2020 |
Differences in Humoral and Cellular Vaccine Responses to SARS-CoV-2 in Kidney and Liver Transplant Recipients
|
Apr/14/2022 |
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models.
|
Jun/01/2021 |
Humoral and cellular responses to spike of delta SARS-CoV-2 variant in vaccinated patients with Immune Mediated Inflammatory Diseases
|
Apr/22/2022 |
Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study
|
Oct/17/2020 |
Impaired SARS-CoV-2-specific T cell reactivity in patients with cirrhosis following mRNA COVID-19 vaccination
|
Oct/27/2021 |
Identification of Highly Conserved SARS-CoV-2 Antigenic Epitopes with Wide Coverage Using Reverse Vaccinology Approach
|
Nov/11/2021 |
Continuous Renal Replacement Therapy With oXiris Filter May Not be an Effective Resolution to Alleviate Cytokine Release Syndrome in Non-AKI Patients With Severe and Critical COVID-19
|
Feb/04/2022 |
BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection.
|
Mar/16/2021 |
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
|
Oct/09/2020 |
Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
|
Mar/03/2022 |
Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniques.
|
Oct/20/2020 |
Synthesis and pharmacological evaluation of choroquine derivatives bearing long aminated side chains as antivirus and anti-inflammatory agents
|
May/11/2020 |
